AKT1 and tuberous sclerosis: Furthermore, the osteogenic efficacy of TSC-EVs on MSCs also returned to the OIM group in the group of TSC-EVs with anti-NGF (Fig. 7L, M), indicating that NGF/Akt signaling offset the effect of anti-NGF treatment on TSC-EVs.